BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou X, Dong L, Shen L. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals. Molecules 2021;26:6997. [PMID: 34834087 DOI: 10.3390/molecules26226997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu J, Cai F, Luo Z, Fan W, Dai J, Cui J, Li S, Geng C, Zheng Q, Wang Z, Tang X. Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers. Eur J Nucl Med Mol Imaging. [DOI: 10.1007/s00259-022-05750-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Santos MA, Irto A, Buglyó P, Chaves S. Hydroxypyridinone-Based Metal Chelators towards Ecotoxicity: Remediation and Biological Mechanisms. Molecules 2022;27:1966. [DOI: 10.3390/molecules27061966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lepareur N. Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals? Front Med 2022;9:812050. [DOI: 10.3389/fmed.2022.812050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]